Clinical Trial Update: Dabigatran Versus Warfarin With NVAF Who Undergo PCI [Phase 4]

View source ↗

Summary

Phase 4 trial comparing dabigatran to warfarin in patients with atrial fibrillation undergoing PCI (post-PCI anticoagulation).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Coronary Artery Disease

Drugs mentioned

• Dabigatran (Dabigatran etexilate)
• Warfarin (warfarin)

Snippet

Sponsor: Shenyang Northern Hospital | Conditions: Atrial Fibrillation, Coronary Artery Disease | Phase 4 | Status: UNKNOWN